Patents by Inventor Phillip Frost

Phillip Frost has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treating mast cell disease
    Patent number: 5057322
    Abstract: A method of treating a patient suffering from mast cell disease comprising daily administration to such patient of from about 1 to about 150 mg of a pure narcotic antagonist, e.g., nalmefene or naltrexone. The antagonist may be administered in divided doses from one to four times daily, preferably by the oral route. Parenteral, transmucosal and transdermal administration may be utilized where suitable.
    Type: Grant
    Filed: August 10, 1990
    Date of Patent: October 15, 1991
    Assignee: Baker Cummins Dermatologicals, Inc.
    Inventor: Phillip Frost
  • Method for treatment of mast cell-mediated dermatologic disorders
    Patent number: 4923875
    Abstract: A method of treating human or animal patients suffering from mast cell-mediated dermatological disorders comprising the administration to the affected skin areas of a topical composition comprising from about 0.01 to about 10% by weight of the narcotic antagonist nalmefene or one of its salts or esters in a pharmaceutically inert topical vehicle. Compositions suitable for use in such methods include solutions, aerosols, creams, gels, ointments and lotions. The compositions may be applied to the affected areas from 1 to about 6 times daily.
    Type: Grant
    Filed: July 10, 1989
    Date of Patent: May 8, 1990
    Assignee: Baker Cummins Pharmaceuticals, Inc.
    Inventor: Phillip Frost
  • Method of treatment for allergic rhinitis
    Patent number: 4880813
    Abstract: A method of treating patients suffering from allergic rhinitis comprises the topical administration to the nasal passages of such patients of a liquid solution containing from about 0.5 to about 10% by weight of the narcotic antagonist nalmefene or a pharmaceutically acceptable salt thereof. The solution may be administered in spray form from a squeeze bottle or from a dropper. Administration of from about 10 to about 200 microliters of the solution into each nostril may be repeated from 1 to 5 times daily.
    Type: Grant
    Filed: July 22, 1988
    Date of Patent: November 14, 1989
    Assignee: Baker Cummins Pharmaceuticals, Inc.
    Inventor: Phillip Frost